P4L (p.Pro4Leu) variant of APOH (Beta-2-glycoprotein 1)
P4L (p.Pro4Leu) in APOH (Beta-2-glycoprotein 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.14 / 1. The record also includes population frequency data and structural context.
P4L (p.Pro4Leu) variant details
- p.Pro4Leu
- NCI-TCGA Cosmic COSV5277
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.139
- REVEL 0.07
- CADD 14.70
- PolyPhen-2 0.00
- SIFT 0.31
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available